Immucor Message Board - Msg: 8856418

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Thomas Kirwin who wrote (307)	4/12/1999 12:41:00 PM
From: Mason Barge	of 422

The base-rate daily volume appears to have picked up a little. In the past we've seen almost no trading interspersed with several days of frantic activity everytime there is a significant announcement. But to my casual observation, it seems that the base-rate volume is increasing, no doubt due to the stock popping up on growth screens. You'd have to think that the stock is starting to interest value investors. Anybody who researches the co. carefully would probably conclude that the high increased earnings is not in any way a spike, but a representation of solid and increasing growth. At .13 on an annualized basis -- a perfectly sound form of analysis for earnings that are expected to be ongoing -- you get a PE of 18.5, rather conservative for a company this well-positioned in terms of growth potential, management, and financial stability. I bought this as a speculative investment and find myself a convinced long-termer. They need to start paying some yield at some point to really get the value people slavering, especially when Gallup runs out of companies to buy. Something in the 1% range would be very nice for starters.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next